ICI to Acquire Emulsion Powders Business from Celanese

ICI has agreed to acquire the Celanese emulsion powders business for 25.5m US$ (14.6m GBP) in cash. The business recorded sales of 32 million euro (21.8m GBP) and operating profit of 1.9 million euro(1.3 m GBP) in 2004, has about 50 employees, and is based in Frankfurt, Germany. The value of the gross assets being acquired is 11 million euro (7m GBP).

This will be the first significant bolt-on acquisition made by ICI for several years. It will strengthen National Starch's Elotex business unit and create the opportunity for significant synergies between the two businesses. The move follows several years of good progress strengthening ICI's balance sheet and improving underlying cash flow. Elotex, which is part of National Starch and Chemical's speciality polymers division, is a leading international producer of polymeric additives used to enhance the properties of building materials such as ceramic tile adhesives, repair mortars, grouts, floor screeds and wallpaper adhesives. The acquisition of the Celanese emulsion powders business will extend the range of Elotex's end markets and applications and will provide additional growth opportunities and increased geographic coverage. The transaction is expected to be completed in Q3, subject to regulatory approval and employee consultation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.